Senvest Management’s Syneron Medical Ltd ELOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-2,202,272
Closed -$23.2M 72
2017
Q1
$23.2M Sell
2,202,272
-1,575,503
-42% -$15.2M 1.66% 22
2016
Q4
$31.7M Sell
3,777,775
-65,476
-2% -$513K 2.26% 17
2016
Q3
$27.5M Hold
3,843,251
1.97% 21
2016
Q2
$29.6M Sell
3,843,251
-31,100
-0.8% -$222K 2.42% 13
2016
Q1
$28.3M Sell
3,874,351
-10,000
-0.3% -$71.6K 2.38% 16
2015
Q4
$29.9M Hold
3,884,351
2.25% 18
2015
Q3
$27.8M Buy
3,884,351
+196,200
+5% +$1.89M 2% 21
2015
Q2
$39.2M Hold
3,688,151
2.45% 16
2015
Q1
$45.7M Hold
3,688,151
2.83% 9
2014
Q4
$34.4M Buy
3,688,151
+4,000
+0.1% +$38.6K 2.45% 17
2014
Q3
$36.9M Hold
3,684,151
3.46% 9
2014
Q2
$38M Buy
3,684,151
+51,615
+1% +$558K 3.32% 11
2014
Q1
$45.2M Buy
+3,632,536
New +$43M 3.52% 7
2013
Q4
Sell
-2,988,261
Closed -$25.8M 105
2013
Q3
$25.8M Buy
2,988,261
+55,877
+2% +$482K 2.86% 11
2013
Q2
$25.5M Buy
+2,932,384
New +$26.2M 3.3% 9

Other funds holding ELOS

Senvest Management's ELOS Position: Q2 2017 in Review

Senvest Management sold out of Syneron Medical Ltd (ELOS) in Q2 2017, closing a stake of 2,202,272 shares — an estimated $23.2M sold.

Senvest Management first reported a position in ELOS in Q2 2013 and held it in 15 quarters. The position peaked at $45.7M in Q1 2015. 79 funds tracked by Wall St. Rank hold ELOS as of Q2 2017.

  • Senvest Management reported no remaining Syneron Medical Ltd position as of Q2 2017 after selling out during the quarter.
  • Senvest Management sold 2,202,272 Syneron Medical Ltd shares in Q2 2017, an estimated $23.2M.
  • Senvest Management first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 15 quarters.
  • Senvest Management's Syneron Medical Ltd position peaked at $45.7M in Q1 2015.
  • 79 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q2 2017.

Based on Senvest Management's 13F filing for Q2 2017, filed 11 Aug 2017.